Page 69 - TequioVol1No2

Los virus /López y Gabriel/57-67 67

Sullivan, R., Dezube, B. J. y Koon, H. B. (2006). Signal Verma, S. C., Borah, S. y Robertson, E. S. (2004).
transduction targets in Kaposi’s sarcoma. Curr Opin Latency-associated nuclear antigen of Kaposi’s
Oncol, 18(5), 456-462. sarcoma-associated herpesvirus up-regulates
transcription of human telomerase reverse
Sxevik, M. (2012). Oncogenic viruses and transcriptase promoter through interaction with
mechanisms of oncogenesis. Turk J Vet Anim Sci, 36, transcription factor Sp1. J Virol, 78(19), 10348-
323-329. 10359.

Tamori, A., Yamanishi, Y., Kawashima, S., Kanehisa, Yan, L., Anderson, G. M., DeWitte, M. y Nakada, M.
M., Enomoto, M., Tanaka, H., Kubo, S., Shiomi, S. y T. (2006). Therapeutic potential of cytokine and
Nishiguchi, S. (2005). Alteration of gene expression chemokine antagonists in cáncer therapy. Eur J
in human hepatocellular carcinoma with integrated Cancer, 42(6), 793-802.
hepatitis B virus DNA. Clin Cancer Res., 11(16),
5821-5826. Yokota, J. ( 2000). Tumor progression and metastasis.
Carcinogenesis, 21, 497-503.
Thomas, D. L., Astemborski, J., Rai, R. M., Anania,
F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. Young, L. S. (2004). Epstein-Barr virus: 40 years on.
E., Strathdee, S. A., Johnson, L., Laeyendecker, O., Nature Rev. Cancer, 4, 757-768.
Boitnott, J., Wilson, L. E. y Vlahov, D. (2000). The
natural history of hepatitis C virus infection: host, Zheng, Z. (2010). Viral oncogenes, noncoding RNAs,
viral, and environmental factors. JAMA, 284(4), and RNA splicing in human tumor viruses. Int. J. Biol.
450-456. Sci., 6, 730-755.

Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K. y Uchino, Zou, W. (2005). Immunosuppressive networks in
H. (1977). Adult T-cell leukemia: clinical and hematologic the tumour environment and their therapeutic
features of 16 cases. Blood, 50(3), 481-492. relevance. Nat Rev Cancer, 5, 263-74.

Detalle de "mayo primaveral" , Itzel Sánchez.

Tequio, vol. 1, no. 2, enero-abril, 2018